A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer

International Journal of Oncology

Volumn 41, Issue 2, 2012, Pages 745-752

  Weichhaus, Michael ^a   Broom, John ^a   Wahle, Klaus ^b   Bermano, Giovanna ^a  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apoptosis; Breast cancer; Cell cycle; Cell proliferation; Cell signalling; Insulin resistance; Obesity

Indexed keywords

CYCLIN D; CYCLIN E; ESTROGEN RECEPTOR; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN RESISTANCE; MENOPAUSAL SYNDROME; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D; CYCLIN E; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INSULIN; INSULIN RESISTANCE; MAP KINASE SIGNALING SYSTEM; OBESITY; PHOSPHORYLATION; POSTMENOPAUSE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN;

EID: 84863576934     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1480     Document Type: Article

References (34)

1. Flegal KM, Carroll MD, Kuczmarski RJ and Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22: 39-47, 1998. (Pubitemid 28036587)
2. Flegal KM, Carroll MD, Ogden CL and Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241, 2010.
3. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003. (Pubitemid 36459468)
4. Antuna-Puente B, Feve B, Fellahi S and Bastard JP: Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34: 2-11, 2008.
5. Facchini FS, Hua N, Abbasi F and Reaven GM: Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86: 3574-3578, 2001. (Pubitemid 32755946)
6. Larsson SC, Mantzoros CS and Wolk A: Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121: 856-862, 2007. (Pubitemid 47106217)
7. Pisani P: Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114: 63-70, 2008.
8. Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Tehard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D, Tumino R, Panico S, Sacerdote C, Sieri S, van Gils CH, Buenode-Mesquita BH, Gonzalez CA, Ardanaz E, Larranaga N, Garcia CM, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Slimani N, Riboli E and Kaaks R: Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119: 659-667, 2006. (Pubitemid 43955721)
9. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD and Strickler HD: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101: 48-60, 2009.
10. Garmendia ML, Pereira A, Alvarado ME and Atalah E: Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol 17: 403-409, 2007. (Pubitemid 46784023)
11. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D and Goodwin PJ: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120, 1998. (Pubitemid 28046082)
12. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B and Hood N: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20: 42-51, 2002. (Pubitemid 34032594)
13. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN and Hankinson SE: Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16: 161-164, 2007. (Pubitemid 46174280)
14. Alokail MS, Al-Daghri NM, Al-Attas OS and Hussain T: Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women. Cardiovasc Diabetol 8: 33, 2009.
15. Purohit A, Newman SP and Reed MJ: The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4: 65-69, 2002. (Pubitemid 34248122)
16. Stephenson GD and Rose DP: Breast cancer and obesity: an update. Nutr Cancer 45: 1-16, 2003. (Pubitemid 36736886)
17. Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, Ando S and Sisci D: Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr Cancer Drug Targets 8: 597-610, 2008.
18. Straus DS: Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 5: 356-369, 1984.
19. Whittaker J, Okamoto AK, Thys R, Bell GI, Steiner DF and Hofmann CA: High-level expression of human insulin receptor cDNA in mouse NIH 3T3 cells. Proc Natl Acad Sci USA 84: 5237-5241, 1987. (Pubitemid 17119121)
20. Osborne CK, Bolan G, Monaco ME and Lippman ME: Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc Natl Acad Sci USA 73: 4536-4540, 1976. (Pubitemid 8013935)
21. Costantino A, Milazzo G, Giorgino F, Russo P, Goldfine ID, Vigneri R and Belfiore A: Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Mol Endocrinol 7: 1667-1676, 1993. (Pubitemid 24034249)
22. Monaco ME and Lippman ME: Insulin stimulation of fatty acid synthesis in human breast cancer in long term tissue culture. Endocrinology 101: 1238-1246, 1977. (Pubitemid 8188343)
23. Gross GE, Boldt DH and Osborne CK: Perturbation by insulin of human breast cancer cell cycle kinetics. Cancer Res 44: 3570-3575, 1984. (Pubitemid 14098613)
24. Geier A, Beery R, Haimshon M, Hemi R and Lunenfeld B: Serum and insulin inhibit cell death induced by cycloheximide in the human breast cancer cell line MCF-7. In Vitro Cell Dev Biol 28A: 415-418, 1992.
25. Faridi J, Fawcett J, Wang L and Roth RA: Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation. Am J Physiol Endocrinol Metab 285: E964-E972, 2003. (Pubitemid 37296317)
26. Godden J, Leake R and Kerr DJ: The response of breast cancer cells to steroid and peptide growth factors. Anticancer Res 12: 1683-1688, 1992.
27. Papa V, Milazzo G, Goldfine ID, Waldman FM and Vigneri R: Sporadic amplification of the insulin receptor gene in human breast cancer. J Endocrinol Invest 20: 531-536, 1997. (Pubitemid 28014505)
28. Weichhaus M, Broom I and Bermano G: The molecular contribution of TNF-α in the link between obesity and breast cancer. Oncol Rep 25: 477-483, 2011.
29. Lorincz AM and Sukumar S: Molecular links between obesity and breast cancer. Endocr Relat Cancer 13: 279-292, 2006. (Pubitemid 43886659)
30. Osborne CK, Monaco ME, Lippman ME and Kahn CR: Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long-term tissue culture. Cancer Res 38: 94-102, 1978. (Pubitemid 8253520)
31. Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N and Tajima K: Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4: 239-246, 2003.
32. Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine ID and Vigneri R: Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol Endocrinol 10: 1318-1326, 1996. (Pubitemid 26423222)
33. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID and Vigneri R: Elevated insulin receptor content in human breast cancer. J Clin Invest 86: 1503-1510, 1990. (Pubitemid 20372597)
34. Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW and Schutte M: Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol Cancer Res 5: 195-201, 2007. (Pubitemid 46424000)